Thought Leader Spotlight
Vadim Zorin will be presenting on his extensive experience on autologous culture expanded fibroblast therapy for aesthetics and dermatological conditions at the Pacific Regenerative Medicine Conference in Honolulu November 6-7th .
In his program, he will cover Autologous dermal fibroblasts for the correction of age-related skin changes (SPRS therapy?). Results of 2-year clinical trials and post-marketing clinical studies.
We hope you decide to join us in November for 2 days of dynamic presentations and discussions on the evolving industry of Regenerative medicine.
Registration for attendees, as well as Sponsor and Exhibit opportunities are still available at our website: Pacific Regenerative Medicine Conference
#PRMC2017 #Regenerative #Medicine #conference #Hawaii #meetoahu #meethawaii
Associate Managing Editor at SciTechnol
7 年Hope you are good and doing well with your research. Journal of Regenerative Medicine is pleased to announce call for papers for its upcoming issue (Volume-6-2017) and welcomes submission of original and significant contributions. We have read your recently published articles. Which made a very good impact among the readers and has added a very valuable paper to the regenerative medicine society? We with an immense interest appeal you to contribute a paper for our journal which will help in the progress of our journal. Papers may be submitted in the form of research articles, reviews, abstracts, article-commentaries, book reviews, rapid communications, letters to the editor, annual meeting abstracts, conference proceedings, case-reports etc… from any discipline related to Stem Cells, Regenerative Science, Tissue Engineering, Stem Cell Therapies, Translational Medicine, Gene Therapy, etc. Journal follows 21days double blind peer review process, where the Handling Editor provides final decision on the manuscript review. Manuscripts can be submitted via Editorial Manager System or E-mail us at [email protected] or [email protected] An acknowledgment letter will be issued upon successful submission of the manuscript. For more details please visit our Journal. It will be very kind of you if you can acknowledge the receipt of this email and give your opinion to our proposal. Please let me know if I can provide any further information. Thank you. Best Regards, Gedela VK, Journal Coordinator Journal of Regenerative Medicine Tel: +1-650-268-9744, E-mail: [email protected] SciTechnol